Premarket analyst action - healthcare

|By:, SA News Editor

SAGE Therapeutics (NASDAQ:SAGE) initiated with Buy rating and $230 (49% upside) price target at Ladenburg Thalmann.

Alkermes plc (NASDAQ:ALKS) initiated with Buy rating and $60 (29% upside) price target at B Riley FBR.

Inogen (NASDAQ:INGN) initiated with Sector Weight rating at Keybanc.

Tonix Pharmaceuticals Holding (NASDAQ:TNXP) initiated with Buy rating and $8 (130% upside) price target at B Riley FBR.

Enanta Pharmaceuticals (NASDAQ:ENTA) initiated with Buy rating and $133 (36% upside) at Roth Capital.

Medtronic (NYSE:MDT) resumed with Market Perform rating at William Blair.

Cigna (NYSE:CI) upgraded to Buy with a $212 (24% upside) price target at Goldman Sachs. Shares up 2% premarket.

Healthcare Services Group (NASDAQ:HCSG) upgraded to Outperform at William Blair. Shares up 2% premarket.

MEI Pharma (NASDAQ:MEIP) upgraded to Outperform with an $11 (165% upside) price target at Wells Fargo. Shares up 8% premarket.

Valeant Pharmaceuticals (NYSE:VRX) upgraded to Overweight at Barclays. Shares up 2% premarket.

Perrigo (NASDAQ:PRGO) downgraded to Equal Weight at Barclays. Shares down a fraction premarket.

Protagonist Therapeutics (NASDAQ:PTGX) downgraded to Equal Weight at Barclays.